Pediatric sinonasal rhabdomyosarcoma: A case report

Area of Science:

• Pediatric Oncology
• Rhabdomyosarcoma Research
• Nasal Cavity Malignancies

Background:

• Pediatric sinonasal rhabdomyosarcoma (PSR) is exceptionally rare.
• It presents as an aggressive malignancy with historically poor patient outcomes.
• Optimal therapeutic strategies for PSR remain undefined.

Purpose of the Study:

• To report a case of embryonal pediatric sinonasal rhabdomyosarcoma.
• To detail the clinical presentation and treatment course.
• To contribute to the limited literature on PSR management.

Main Methods:

• Case report of a 2-year-old girl with embryonal PSR.
• Initial treatment involved surgical resection.
• Adjuvant chemotherapy administered with vincristine and actinomycin-D.

Main Results:

• Tumor recurrence detected at 10 months post-initial treatment.
• Salvage surgery followed by resumed chemotherapy.
• Patient succumbed to disease progression, fungal bronchopneumonia, and septic shock 12 months after diagnosis.

Conclusions:

• This case illustrates the aggressive nature and poor prognosis of pediatric sinonasal rhabdomyosarcoma.
• Treatment challenges and the need for novel therapeutic approaches are evident.
• Further research is crucial for improving outcomes in pediatric sinonasal rhabdomyosarcoma.